Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
iPLATO Healthcare Ltd
| Project | Democratising Cancer Screening Uptake |
|---|---|
| Description |
In partnership with Southeast London Cancer Alliance, iPLATO are aiming to increase early detection of Bowel Cancer, with a particular focus on engaging with ethnic minority communities. Using a multi-layered digital approach, cohorts such as those with protected characteristics, or social exclusion will be invited digitally with supporting educational content. |
| Funding | £ 1,669,274 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer |
| Health Innovation Network Partner | Imperial College Health Partners AHSN |
| Website | https://www.iplato.com/ |
Skin Analytics Ltd
| Project | Streamlining Early Diagnostic Skin Cancer Assessments in the Community using a Class II UKCA-Certified Artificial Intelligence Medical Device |
|---|---|
| Description |
Skin Analytics’ Class II UKCA-Certified Artificial Intelligence Medical Device can support the assessment of skin lesions where there is a suspicion of skin cancer. This technology will be deployed in Community Diagnostic Hubs in pathways co-created with three NHS partners to support faster skin cancer detection and pathway conversion rates. |
| Funding | £ 2,157,038 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer , Skin |
| Health Innovation Network Partner | Imperial College Health Partners AHSN |
| Website | https://skin-analytics.com/ |
Cyted
| Project | Project CYTOPRIME2: Earlier Oesophageal Cancer Detection in Primary Care |
|---|---|
| Description |
This non-endoscopic test for the earlier detection of oesophageal cancer is transforming the care pathway for people living with chronic reflux. Project CYTOPRIME2 will test patients at risk of cancer in primary and community care across the East of England, North West Coast and Wessex Cancer Alliance regions. |
| Funding | £ 3,352,261 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Health Innovation Network Partner | North West Coast AHSN |
| Website | https://cyted.ai |